Publications:

Biochemical characterization of the interaction between KRAS and Argonaute 2.

Biochemistry And Biophysics Reports

Waninger, Jessica J JJ; Beyett, Tyler S TS; Gadkari, Varun V VV; Siebenaler, Ronald F RF; Kenum, Carson C; Shankar, Sunita S; Ruotolo, Brandon T BT; Chinnaiyan, Arul M AM; Tesmer, John J G JJG

Publication Date: 2022-03

Variant appearance in text: KRAS: Y64G

PubMed Link: 34988297

Variant Present in the following documents:

• Main text
• main.pdf

View BVdb publication page

KRAS insertion mutations are oncogenic and exhibit distinct functional properties.

Nature Communications

White, Yasmine Y; Bagchi, Aditi A; Van Ziffle, Jessica J; Inguva, Anagha A; Bollag, Gideon G; Zhang, Chao C; Carias, Heidi H; Dickens, David D; Loh, Mignon M; Shannon, Kevin K; Firestone, Ari J AJ

Publication Date: 2016-02-08

Variant appearance in text: KRAS: Y64G

PubMed Link: 26854029

Variant Present in the following documents:

• ncomms10647.pdf

View BVdb publication page

Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.

Blood

Shieh, Angell A; Ward, Ashley F AF; Donlan, Kegan L KL; Harding-Theobald, Emily R ER; Xu, Jin J; Mullighan, Charles G CG; Zhang, Chao C; Chen, Shann-Ching SC; Su, Xiaoping X; Downing, James R JR; Bollag, Gideon E GE; Shannon, Kevin M KM

Publication Date: 2013-06-13

Variant appearance in text: KRAS: Y64G

PubMed Link: 23637129

Variant Present in the following documents:

• Main text

View BVdb publication page